A Population-Based Study of Pharmacogenetics and Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$89,430
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
G2005044
Summary
Beta-blockers are a common class of medication used to lower intraocular pressure. Interestingly, this same class of medications is used orally to treat high blood pressure, and genetics have been shown to play a role in how a person responds to this medication. Dr. McCarty believes that genetics is also associated with how a person responds to a prescription for medication to lower intraocular pressure. Her goal is to ultimately improve treatment of patients with glaucoma and ocular hypertension. In the future this study may lead to an assessment as to whether prescription medications based on genotype would improve cost effectiveness and preserve visual function in people with glaucoma and intraocular hypertension.
Related Grants
National Glaucoma Research
How Neural Activity Shapes Vision Recovery in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Yvonne Ou, MD
Current Organization
University of California, San Francisco
How Neural Activity Shapes Vision Recovery in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Yvonne Ou, MD
Current Organization
University of California, San Francisco
National Glaucoma Research
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Myoungsup Sim, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Foot-Based Monitoring and Feedback to Improve Mobility and Reduce Falls in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Navid Amini, PhD
Current Organization
California State University, Los Angeles
Foot-Based Monitoring and Feedback to Improve Mobility and Reduce Falls in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Navid Amini, PhD
Current Organization
California State University, Los Angeles